Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

588
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
588
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

360
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
360
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

441
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
441
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

335
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
335
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

491
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
491
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

161
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
161

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Corrigendum to "Oleanolic acid 28-O-β-D-glucopyranoside alleviates TNBS-induced ulcerative colitis in rat by regulating Nrf2/x-CT/GPX4-mediated ferroptosis" [Journal of Ethnopharmacology 353 (2025) 120369].

Journal of ethnopharmacology·2026
Same author

Targeting barrier integrity: Pseudoginsenoside RT2 ameliorates ulcerative colitis by driving epithelial renewal via the Wnt/β-catenin pathway.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Elevating RNA m<sup>5</sup>C methylation provides a promising strategy for crop productivity.

National science review·2026
Same author

Research landscape, knowledge structure, and emerging frontiers of robot-assisted surgery for urolithiasis: a bibliometric and visualization analysis.

Journal of robotic surgery·2026
Same author

Laparoendoscopic single-site versus conventional laparoscopic living donor nephrectomy: a systematic review and meta-analysis of randomized controlled trials.

International urology and nephrology·2026
Same author

Multi-omics integration maps CHH methylation and gene regulatory networks across heat, drought, and salt stress in rice.

Cell reports·2026

関連する実験動画

Updated: May 5, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K

プラセンタ・アクレタスペクトルにおける有害な臨床結果の予測のための解釈可能な機械学習モデルの開発と検証:多中心研究

Hongliang Li1, Yueyue Zhang2, Hangru Mei3

  • 1Department of Radiology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China (H.L., Y.Y., L.W., X.C., K.W., H.L.).

Academic radiology
|August 23, 2025
PubMed
まとめ

新しい機械学習モデルは,MRIと臨床データを用いて,胎盤アクレタスペクトル (PAS) の悪影響を正確に予測します. パーソナライズされたPAS患者の管理を助けるためのオンラインツールがあります.

キーワード:
不良な臨床結果機械学習モデル解釈性胎盤 アクレタ スペクトル

さらに関連する動画

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

423

関連する実験動画

Last Updated: May 5, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

423

科学分野:

  • 医学画像と診断
  • 医療における機械学習
  • 周産医療

背景:

  • 胎盤増殖スペクトル (PAS) は,正確なリスク識別を必要とする重篤な妊娠合併症です.
  • 高リスクのPAS患者の早期発見は,適応した治療戦略に不可欠です.
  • 現在の診断方法は,高度な予測モデルから利益を得ることができます.

研究 の 目的:

  • 機械学習モデルを開発し,PASにおける有害な結果を予測する.
  • 予測の精度を高めるために,MRIの形態学的指標と臨床的特徴を統合する.
  • リアルタイムのPASリスク評価のためのアクセシブルなオンラインツールを作成します.

主な方法:

  • 2つのセンターの125人のPAS患者を遡って分析した.
  • MRIと臨床データを用いた機械学習モデル (AdaBoost,TabPFN,CatBoost) の開発と検証
  • モデル解釈性とウェブプラットフォームによる展開のためのSHAP分析.

主要な成果:

  • CatBoostモデルは,AUROC 0.90 (内部) と 0.84 (外部検証) で高いパフォーマンスを示した.
  • 主な予測要因は,子宮頸管の長さ,妊娠年齢,前回の剖検,胎盤血管の異常,出産でした.
  • リアルタイムのリスク予測と視覚化を提供する解釈可能なオンラインツールが開発されました.

結論:

  • 有害なPAS結果を予測するための解釈可能な実用的な機械学習モデルが開発されました.
  • オンラインの予測ツールは,パーソナライズされたPAS患者の管理のための臨床的意思決定を支援することができます.
  • このアプローチは,PASにおける予測モデリングの臨床適用性を高めます.